Characterization of a REST-Regulated Internal Promoter in the Schizophrenia Genome-Wide Associated Gene MIR137 by Warburton, Alix et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1093/schbul/sbu117
Document Version
Publisher's PDF, also known as Version of record
Link to publication record in King's Research Portal
Citation for published version (APA):
Warburton, A., Breen, G., Rujescu, D., Bubb, V. J., & Quinn, J. P. (2014). Characterization of a REST-Regulated
Internal Promoter in the Schizophrenia Genome-Wide Associated Gene MIR137. Schizophrenia Bulletin, 41(3),
698–707. 10.1093/schbul/sbu117
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 18. Feb. 2017
698
Schizophrenia Bulletin vol. 41 no. 3 pp. 698–707, 2015 
doi:10.1093/schbul/sbu117
Advance Access publication August 25, 2014
© The Author 2014. Published by Oxford University Press on behalf  of the Maryland Psychiatric Research Center.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), 
which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Characterization of a REST-Regulated Internal Promoter in the Schizophrenia 
Genome-Wide Associated Gene MIR137
Alix Warburton1, Gerome Breen2,3, Dan Rujescu4, Vivien J. Bubb1, and John P. Quinn*,1 
1Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool L69 
3BX, UK; 2King’s College London, MRC Social Genetic and Developmental Psychiatry Research Centre, Institute of Psychiatry, 
London, UK; 3National Institute for Health Research (NIHR), Biomedical Research Centre for Mental Health, South London and 
Maudsley NHS Foundation Trust and Institute of Psychiatry, King’s College London SE5 8DF, UK; 4Department of Psychiatry, 
University of Halle-Wittenberg, Halle, Germany
*To whom correspondence should be addressed; Department of Molecular and Clinical Pharmacology, University of Liverpool, Crown 
Street, Liverpool L69 3BX, UK; tel: +44-151-794-5498, fax: +44-151-794-5517, e-mail: jquinn@liverpool.ac.uk
MIR137 has been identified as a candidate gene for 
schizophrenia from genome-wide association studies 
via association with an intronic single nucleotide poly-
morphism (SNP), rs1625579. The location of the SNP 
suggests one mechanism in which transcriptional or post-
transcriptional regulation of miR-137 expression could 
underlie schizophrenia. We identified and validated a 
novel promoter of the MIR137 gene adjacent to miR-137 
itself which can direct the expression of distinct mRNA 
isoforms encoding miR-137. Analysis of both endogenous 
gene expression and reporter gene assays determined 
that this internal promoter is regulated by repressor ele-
ment-1 silencing transcription factor (REST), which has 
previously been associated with pathways linked to schizo-
phrenia. Distinct isoforms of REST mediate differential 
expression at this locus, suggesting the relative levels of 
these isoforms are important for miR-137 expression 
profiles. The internal promoter contains a variable num-
ber tandem repeat (VNTR) domain adjacent to the pre-
miR-137 sequence. The reporter gene activity directed by 
this promoter was modified by the genotype of the VNTR. 
Differential expression was also observed in response to 
cocaine, which is known to regulate the REST pathway 
in SH-SY5Y cells. Our data support the hypothesis that 
a “gene × environment” interaction could modify the level 
of miR-137 expression via this internal promoter and that 
the genotype of the VNTR could modulate transcriptional 
responses. We demonstrate that this promoter region is not 
in disequilibrium with rs1625579 and therefore would sup-
ply a distinct pathway to potentially alter miR-137 levels 
in response to environmental cues.
Key words:  cocaine/gene environment interaction/ 
microRNA-137/variable number tandem repeat
Introduction
Genome-wide association study (GWAS) for schizophre-
nia identified the intronic single nucleotide polymorphism 
(SNP) rs1625579 within the MIR137 gene to be strongly 
associated.1 The risk genotype for this variant is a strong 
predictor for earlier age-at-onset of psychosis and is asso-
ciated with structural changes within the brain relative 
to carriers of the protective allele and healthy matched 
controls.2 MIR137 encodes for the microRNA-137 (miR-
137), which functions in neurodevelopment, adult neuro-
genesis3,4 and is a validated regulator of GWAS candidate 
genes for schizophrenia,1,5,6 suggesting that impairments 
in the regulation and/or function of miR-137 may be a 
key mechanism in neuropsychiatric disease.
Bioinformatic analysis of the MIR137 locus predicted 
an internal promoter adjacent to the miR-137 sequence 
(figure 1). This promoter encompassed a variable number 
tandem repeat (VNTR), which has previously been shown 
to modulate the processing and function of miR-137.7 
VNTRs at other loci can be clinical correlates of psychiat-
ric dysfunction.8,9 We postulated there to be transcriptional 
properties associated with the MIR137 VNTR because we 
have demonstrated that VNTRs can act as transcriptional 
regulators in both a tissue-specific and stimulus-inducible 
manner.10–18 ENCODE (Encyclopedia of DNA Elements) 
ChIP-Seq data indicated that repressor element-1 silenc-
ing transcription factor (REST),19 also termed neuron 
restrictive silencing factor (NRSF),20 was binding at this 
internal promoter. REST predominantly functions as 
a transcriptional repressor of neuronal gene expression 
through binding the RE1 (repressor element-1) or NRSE 
(neuron restrictive silencing element).19,20 Modulation of 
REST is associated with neurological dysfunction, includ-
ing schizophrenia,21 with genetic variants being implicated 
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Functional Analysis of Internal MIR137 Promoter
Fig. 1. (A) Schematic showing the nonprotein coding genes MIR137HG (AK094607), AK311400, and AK309618 as described in the 
UCSC Genome Browser, Assembly GRCh37/hg19. Exons represented as black boxes; introns as connecting lines. The numbers above 
indicate size in bp, unless stated otherwise. The direction of transcription is indicated by a dashed arrow. MicroRNA (miR)-137 and miR-
2682 are denoted by dark grey boxes. A 15-bp variable number tandem repeat (VNTR) immediately upstream of miR-137 is represented 
as a light grey bar. REST binding sites identified from ENCODE ChIP-seq data are marked as vertical arrows i and ii. Lower panel, 
Transcription factor binding and histone marks over the internal MIR137 promoter from ENCODE data. (B) Sequence targeted by PCR 
primers for the internal MIR137 promoter. PCR primer sequences are marked by horizontal arrows; the double horizontal arrow marks the 
alternative forward primer targeting the VNTR alone. Upper case font indicates exons and lower case font introns. The VNTR sequence is 
boxed; the repetitive element is marked with brackets, n representing copy-number variation. Underlined text indicates miR-137 sequence. 
Sequence marked with asterisks’ represents predicted REST binding sites identified using rVista 2.0 (http://rvista.dcode.org/).
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in cognitive function.22 REST has several isoforms, most 
noticeably a truncated isoform known as sNRSF in 
human cells and related to REST4 in rodent cells, which 
has been shown to have distinct functions from full-length 
REST and whose expression is often associated with cel-
lular stress or disease progression.23–29
In this communication, we address the transcriptional 
mechanisms that may operate at the proposed internal 
promoter to modulate cellular miR-137 levels. The result-
ing changes in miR-137 levels could underpin a pathway 
modulating schizophrenia.
Methods
Plasmid Construction
MIR137 fragments were cloned into the pGL3 Luciferase 
reporter vector system as detailed in supplementary S1.1.
Cell Culture
Human SH-SY5Y neuroblastoma cells were maintained 
as described previously.30 For drug challenge, 10 µM 
cocaine or vehicle alone (sterile water) were diluted in 
appropriate volumes of cell culture media and added to 
the cells for 1 hour. For luciferase assays, drug treatments 
were performed 4 hours posttransfection.
Luciferase Reporter Gene Assays
SH-SY5Y cells were seeded in 24-well plates at 100 000 
cells per well and transfected with 1 µg plasmid DNA 
and 10 ng pMLuc2 (Novagen) (internal control for trans-
fection efficiency) using TurboFect (Thermo Scientific). 
Transfected cells were processed 48 hours posttransfec-
tion using the Dual-Luciferase Reporter Assay System 
(Promega). Fold changes in firefly luciferase activity 
(normalized to renilla luciferase activity) supported by 
the MIR137 domains over the pGL3 controls were calcu-
lated and significance determined using one-tailed t tests. 
Significance was scored as follows */#P < .05, **/##P < 
.01, ***/###P < .001. For each transfection, n = 4.
REST Overexpression Assays
For luciferase reporter gene assays, SH-SY5Y cells were pro-
cessed with the addition of 1 µg RE-EX1 plasmid,29 express-
ing full-length human REST or sNRSF in the pcDNA3.1 
vector system. For gene expression profiling, SH-SY5Y 
cells were seeded in 6-well plates at 400 000 cells per well 
and transfected with either 4 µg of RE-EX1 or pcDNA3.1_
sNRSF. pcDNA3.1 alone was used as a negative control. 
Cells were incubated for 48 hours before being processed.
RNA Extraction and Gene Expression Profiling
Total RNA was extracted using Trizol Reagent 
(Invitrogen). RNA concentration was determined using 
a NanoDrop-8000 spectrophotometer and 2 µg reverse 
transcribed into cDNA using the GoScript RT system. 
The total reaction volume of 20 µl was diluted 20× in 
nuclease free water and 1 µl cDNA used per 25 µl PCR 
reaction using GoTaq Flexi DNA Polymerase and PCR 
primers for the MIR137 transcripts (supplementary 
S1.2).
Chromatin Immunoprecipitation
Cells were grown to 80% confluence in T175 flasks and 
treated for 1 hour under one of the following conditions: 
basal (untreated), 1 or 10 µM cocaine or vehicle alone. 
Samples were processed following methods described by 
Murgatroyd et al.31 Immunoprecipitation was performed 
using anti-NRSF (H-290) (Santa Cruz Biotechnology), 
which recognizes amino acids 1–290 of human REST. 
PCR analysis of the immunoprecipitated chromatin sam-
ples was performed using primers targeting 2 predicted 
REST binding sites (BS) across the MIR137 locus (fig-
ure  1) and BDNF promoter 2 as a positive control for 
REST binding.27,32 Primer sequences are detailed in sup-
plementary S1.2.
Results
Bioinformatic Analysis of the Human MIR137 Locus
MIR137 is located on chromosome 1p22 within the 
nonprotein coding RNA genes MIR137HG (MIR137 
host gene/AK094607),7 AK311400,33 and AK309618. 
Within the primary (pri)-miRNA-137 sequence, there is 
a 15-bp VNTR, 6 bp upstream of the precursor (pre)-
miRNA-137 from which the functional mature miRNA-
137 (miR-137) is processed7 (figure  1A). ChIP-seq data 
from ENCODE34,35 identified only RNA Polymerase 
II and the transcription factor REST binding over the 
MIR137 VNTR (position, chr1:98511662-98511917, 
hg19). ENCODE data also identified REST occupancy 
within the first intron of MIR137HG (chr1:98513800-
98514144, hg19). The rVista portal36 also supported 
REST binding at the VNTR adjacent to pre-miR-137 
(position, chr1:98511764-98511782, hg19) from the 
Transfac database.37 The genomic architecture surround-
ing the MIR137 gene, such as active histone marks and 
CpG islands identified from UCSC data, suggested a 
promoter in this region, and we hypothesized it could be 
important for the regulation of miR-137 expression and 
the expression of neighboring transcripts. We termed this 
putative internal promoter, Imir137 promoter.
Imir137 Promoter Supports Luciferase Reporter Gene 
Expression in the SH-SY5Y Neuroblastoma Cell Line
To assess the function of the putative Imir137 promoter, 
we cloned it into the pGL3-Basic (pGL3B) luciferase 
reporter gene vector. We tested 2 promoter variants, 
containing either a 4- or 12-copy VNTR, specifically we 
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included nucleotides −361/−481 to +38 numbered from the 
first base of the pre-miR-137 sequence as +1 (figure 2A). 
One previous report demonstrated that the low (3-copy) 
and high (12-copy) VNTRs differentially affected miR-
137 processing in vitro.7 We similarly compared their abil-
ity to modulate transcription. The difference in the 5′ end 
of these fragments reflected the two distinct VNTRs and 
were termed Imir137(4) and Imir137(12), respectively. We 
clearly demonstrated the ability of Imir137 to act as a 
promoter, observing a 65.0- or 75.0-fold increase in acti-
vation when containing either the 4- or 12-copy repeats, 
respectively, in the forward orientation (figure 2B, ***P < 
.001). Consistent with promoter function in this domain, 
the reverse orientation had no activity. A small but sig-
nificant difference (##P < .01) was observed when the 
two alleles were compared with one another.
To determine whether any effect was contributed by 
the VNTR alone, we cloned 2 variants of  this domain, 
either −86 or −206 to +38 bp (reflecting the 4- and 
12-copy repeats) into the pGL3-Promoter (pGL3P) vec-
tor, upstream of  the minimal SV40 promoter in forward 
and reverse orientations (figure 2A). These were termed 
VNTRmir137(4)F or R and VNTRmir137(12)F or R, 
respectively, to indicate both copy number and orienta-
tion of  fragment. The 4-copy variant supported a small 
increase in reporter activity, whereas the 12-copy vari-
ant repressed activity; this resulted in a significant dif-
ference in activity when the 2 VNTRs in the forward 
orientation were compared with one another (figure 2C; 
###P < .001).
REST Can Bind to the Imir137 Promoter Region and 
Modulate Its Activity in a Stimulus-Inducible and 
Allele-Dependent Manner
There are 2 predicted REST BS at the MIR137 locus, 
which we term BSi and BSii (figures 3A and 3B). To vali-
date REST occupancy, we performed chromatin immu-
noprecipitation (ChIP) assays in SH-SY5Y cells that are 
homozygous for the 4-copy repeat variant of the MIR137 
promoter VNTR. The antibody recognizes the amino 
terminal of REST and therefore identifies all known iso-
forms of this protein. SH-SY5Y cells express both full-
length REST and the sNRSF isoform. REST binding was 
observed over the Imir137 promoter (BSii) but not at the 
intronic site of MIR137HG (BSi) (figure 3C). To investi-
gate a potential role for REST-mediated regulation of the 
MIR137 locus, we treated SH-SY5Y cells with cocaine, 
which is known to modulate many genes regulated by 
REST.38 After 1 hour of treatment with 1 µM cocaine, 
REST binding was reduced at the Imir137 promoter 
(BSii), with loss of binding observed after 10 µM cocaine 
treatment (figure 3C). As a control, we demonstrated that 
cocaine reduced REST binding at the previously char-
acterized BDNF RE1/NRSE domain (figure  3C).27,32 
The loss of binding to BSii was correlated with loss of 
Fig. 2. Validation of an internal promoter in the MIR137 gene. 
(A) Schematic representation of MIR137 constructs aligned to 
the MIR137 gene showing the 4-copy (Imir137(4)) and 12-copy 
(Imir137(12)) variants of the MIR137 VNTR ± the proximal 
flank region in the pGL3B (Basic) and pGL3P (Promoter) 
vectors, respectively, in forwards (F) and reverse (R) orientation. 
(B,C) Average fold change in luciferase activity supported by the 
MIR137 constructs over vector controls in SH-SY5Y cells. N = 4. 
*Significant changes in luciferase activity over backbone control. 
#Significant changes in luciferase activity between experimental 
conditions. */#P < .05, **/##P < .01, ***/###P < .001.
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Fig. 3. REST modulation of  the MIR137 internal promoter in SH-SY5Y cells. (A) Predicted REST binding sites (BS) across MIR137 
identified using Transcription Factor ChIP-seq from ENCODE, UCSC Genome Browser (http://genome.ucsc.edu/). (B) Canonical 
21 bp binding motif  found within REST target genes and sequence homology with predicted BS within MIR137. (C) Chromatin 
immunoprecipitation (ChIP) assays showing REST binding at the putative BSii encompassing the internal MIR137 promoter 
(Imir137) VNTR under basal conditions and after 1 hour treatment with 1 and 10 µM cocaine. (D) Expression profiling of  mRNAs 
expressed from the MIR137 locus after 1 hour treatment with 10 µM cocaine. (E) Relative levels of  luciferase expression supported by 
the Imir137(4/12)F/R constructs in response to 1 hour treatment with 10 µM cocaine. N = 4. *Significant changes in luciferase activity 
over backbone control levels. #Significant changes in luciferase activity between experimental conditions. */#P < .05, **/##P < .01, 
***/###P < .001.
 at K
ing's College London - Journals D
ept on Septem
ber 7, 2016
http://schizophreniabulletin.oxfordjournals.org/
D
ow
nloaded from
 
703
Functional Analysis of Internal MIR137 Promoter
AK309618 mRNA expression but not MIR137HG and 
AK311400 expression (figure 3D). Cocaine had no effect 
on the level of reporter gene expression supported by 
either Imir137(4) or Imir137(12), which might suggest 
other domains outside the proximal promoter are involved 
in the response of the endogenous gene (figure 3E).
We analyzed the affect of overexpression of full-length 
REST (RE-EX1) and sNRSF on both endogenous 
MIR137 mRNA and reporter gene constructs containing 
the internal promoter in SH-SY5Y cells. Overexpression 
of RE-EX1 but not sNRSF resulted in down-regulation 
of both AK311400 and AK309618 mRNAs whose tran-
scripts initiate from the Imir137 promoter region (fig-
ure 4A). This was not a metabolic or nonspecific affect 
on the cell transcriptome because MIR137HG expres-
sion was not affected (figure  4A). Co-transfection of 
the Imir137 promoter constructs demonstrated a differ-
ential response to either RE-EX1 or sNRSF, dependent 
on the genotype of the VNTR. RE-EX1 overexpres-
sion demonstrated a decrease in reporter gene activity 
on the Imir137(4) (*P < .05), whereas the Imir137(12) 
was not affected (figure 4B). Conversely, sNRSF had no 
affect on Imir137(4) but increased activity supported by 
Imir137(12). The difference between activity supported 
by Imir137(4) and Imir137(12) in response to RE-EX1 
and the truncated isoform sNRSF was 1.4-fold (###P < 
.001) and 1.5-fold (#P < .05), respectively.
When the VNTR domain alone was investigated in 
conjunction with RE-EX1 overexpression, it was noted 
that a small and comparable reduction in activity (##P 
< .01) was seen for both VNTRmir137(4)F (1.2-fold) and 
VNTRmir137(12)F (1.4-fold) (figure  4C). However, the 
greatest difference observed was in response to sNRSF 
overexpression, which resulted in major repression of the 
4-copy VNTR (2.2-fold). There is a potential REST BS 
within the MIR137 VNTR sequence domain (figure 1B).
Allele Frequency of the MIR137 VNTR
To investigate VNTR heterogeneity, we determined 
both allele frequency within the HapMap CEU popu-
lation and linkage to the previously identified GWAS 
SNP, rs1625579. Our analysis indicated that the VNTR 
was not in linkage disequilibrium (LD) with the GWAS 
SNP (supplementary figure S1); however, we identified 
a large number of  variants (4–12 copies) of  the VNTR 
within the CEU population, with a plurality of  individ-
uals (55%) homozygous for the 4-copy variant (Table 1). 
However, the higher copy-number variants of  the 
VNTR were rare, thus giving us little power to address 
the role of  the functionally distinct 12-copy variant 
found both in this communication and previously as a 
modulator of  miR-137 processing in a cell line model,7 
as a simple genetic correlate for risk to schizophre-
nia. Furthermore, we searched for LD using the CEU 
sample panel, integrating the VNTR genotypes using a 
Fig. 4. Differential regulation of the MIR137 locus after 
REST overexpression in SH-SY5Y cells. (A) Expression of 
AK311400, AK309618, and MIR137HG/AK094607 mRNA 
after overexpression of full-length human REST (RE-EX1) 
and sNRSF. Expected band sizes for AK311400, AK309618, 
and MIR137HG were 274, 451, and 291 bp, respectively. (B,C) 
Average fold change in luciferase activity compared to pGL3B (B) 
and pGL3P (C) controls after transfection of MIR137 reporter 
gene constructs under basal conditions or in combination with 
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down coding procedure whereby each allele is coded as a 
SNP depending on its dosage (0,1,2 becoming 11,12,22). 
None of  the SNPs in high LD with the previous GWAS 
finding showed LD with R2 > .05. These results are com-
patible with a VNTR mutating by both recombination 
and homoplasy.
Discussion
The genomic architecture of  the MIR137 gene suggested 
the presence of  a promoter in the region adjacent to 
the sequence of  miR-137 itself  and thus internal to the 
main precursor message. We termed this putative pro-
moter region Imir137. The structure of  this promoter 
was also of  interest as it contained a VNTR domain 
6 bp upstream of the precursor sequence of  miR-137. 
We confirmed the existence of  this novel promoter by 
reporter gene analysis and validated the presence of  2 
mRNAs that originate in this area of  the gene locus, 
AK311400 and AK309618 (figures 2 and 3). We vali-
dated ENCODE data that the REST transcription 
factor bound at this promoter, figure  3. To address 
whether REST was involved in the differential regula-
tion of  mRNAs at the Imir137 promoter, we modulated 
the levels of  REST with an expression construct. This 
resulted in a decrease in both transcripts originating at 
the Imir137 promoter but no affect was observed on the 
expression of  the full-length MIR137HG. This was con-
sistent with the binding observed in ChIP for REST at 
the internal promoter. We further determined that the 
genotype of  the VNTR in the Imir137 promoter region 
could mediate differential reporter gene expression. This 
latter observation was in the presence of  overexpressed 
full-length REST or a truncated isoform, sNRSF. The 
proximal Imir137 promoter and the VNTR were found 
not to be in disequilibrium with the GWAS SNP for 
schizophrenia (supplementary figure S1), and therefore, 
the regulation of  this promoter supplies a distinct path-
way for modulation of  miR-137 levels.
Modulation of epigenetic pathways by REST in asso-
ciation with the SWI/SNF chromatin remodeling com-
plex21 has been implicated in schizophrenia. A  similar 
model involving REST could operate at the MIR137 
locus, in particular at the Imir137 promoter; furthermore, 
such a mechanism could be modified by any genetic vari-
ants embedded at the gene locus, thus further modulat-
ing miR-137 levels. Regulation by REST is complicated 
by the distinct functions that have been assigned to vari-
ous isoforms of this gene. The proteins corresponding to 
these isoforms have not been examined as extensively as 
the full-length protein. The isoform sNRSF used in our 
current study results from the insertion of a small exon 
(N) between the accepted third and fourth exons; the 
inclusion of this exon results in a frame-shift and, with 
it, the introduction of a stop codon at the start of exon 
4 resulting in a truncated protein.26 This is similar to the 
REST4 isoform in rodents.27,28 Overexpression of sNRSF 
resulted in data that were distinct from the action of full-
length REST on both the endogenous MIR137 gene and 
several of the reporter gene constructs. Mechanistically, 
the different REST isoforms have been suggested to have 
distinct regulatory functions, for example, full-length 
REST represses the human synapsin I promoter, whereas 
the truncated REST variant does not.39 Alternatively, the 
truncated isoform has been proposed to act as an antag-
onist of REST-mediated gene repression, for example, 
REST repression of both the BDNF promoter and the 
cholinergic gene locus has been shown to be alleviated 
by the truncated isoform.40,41 Our data on the action 
of REST or the truncated variant on the regulation of 
the endogenous MIR137 gene or the reporter gene con-
structs are consistent with this differential action of 
these distinct REST isoforms. However, SH-SY5Y cells 
endogenously express both isoforms and overexpression 
modulates the ratio of REST/sNRSF in the cell. We pre-
dict that in schizophrenia, environmental challenges and 
stress might result in alterations in the ratios of REST 
Table 1. Genotype and Allele Frequency Data for the MIR137 
Variable Number Tandem Repeat (VNTR) in the HapMap CEU 
Cohort
Number of Counts Frequency (%)
Genotype
 4 4 49 55.06
 4 5 9 10.11
 4 6 10 11.24
 4 7 3 3.37
 4 8 3 3.37
 4 9 2 2.25
 4 10 5 5.62
 4 11 1 1.12
 4 12 1 1.12
 5 6 2 2.25
 6 6 1 1.12
 6 8 2 2.25
 6 9 1 1.12
 Total 89
Allele
 4 132 74.16
 5 11 6.18
 6 17 9.55
 7 3 1.69
 8 5 2.81
 9 3 1.69
 10 5 2.81
 11 1 0.56
 12 1 0.56
 Total 178
Note: Numbers represent copy number of the repeat.
RE-EX1 or sNRSF overexpression constructs. N = 4. *Significant 
changes in luciferase activity over backbone control. #Significant 
changes in luciferase activity between experimental conditions. 
*/#P < .05, **/##P < .01, ***/###P < .001. 
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isoforms that could ultimately result in an altered pattern 
of gene expression. Significantly, the data from reporter 
gene constructs indicated that the genotype of the VNTR 
could modulate the response to the change in REST lev-
els. This would suggest that a gene × environment (G × 
E) factor is driving the modulation of expression over 
the locus.
We identified 3 mRNAs produced over the MIR137 
locus in SH-SY5Y cells: MIR137HG (AK094607), 
AK311400, and AK309618, figures 2 and 4. The differ-
ential regulation of  transcripts from the major MIR137 
promoter and Imir137 would be expected to not only 
vary the levels of  miR-137 but also the ratio of  miR-
137 to a second microRNA at this locus, miR-2682 
(figure  1). The function or significance of  miR-2682 
has not been addressed in previous communications. 
MiR-2682 is not present in the AK311400 transcript. 
Similarly, the different transcripts expressed from this 
region may be posttranscriptionally processed, leading 
to different levels of  either microRNA, which could 
result in central nervous system (CNS) dysfunction. In 
vivo, the modulation of  REST levels that modulate the 
transcripts expressed could be directed by psychologi-
cal stressors or other trauma; however, the action of  the 
drug used in this communication validates the plasticity 
in expression at this locus. Cocaine, a known modula-
tor of  REST expression, resulted in the loss of  expres-
sion of  AK309618—one of  the 2 transcripts predicted 
to originate at the internal promoter region. There was 
no affect on the expression of  AK311400, which would 
originate from a similar position, and the full-length 
MIR137HG (AK094607) transcript (figure 3). We can-
not determine here whether REST levels modulate the 
differential expression of  transcripts directed by the 
Imir137 promoter in response to cocaine; only that this 
drug induces a specific set of  transcriptional responses 
acting at the internal promoter, of  which REST is one. 
Nevertheless, the data are consistent with a central role 
for REST in modulating the activity of  the Imir137 
promoter.
Identification of  the VNTR was of  interest in part 
because the copy number of  this type of  repetitive 
domain within the promoter of  other genes we have 
analyzed, such as MAOA, SLC6A3 or SLC6A4, both 
correlates with susceptibility to a CNS disorder and 
supports differential reporter gene expression.14–17,42–46 
We demonstrated that reporter gene function of  the 
Imir137 promoter was modulated by the genotype of 
the VNTR; we tested the 4- and 12-copy variants based 
on a previous study that addressed a 3- and 12-copy 
variant in a cell line model of  cancer for its ability to 
modulate the processing of  the mature miR-137.7 We 
did not test each individual repeat in vitro because 
although we could perform reporter gene analysis, it 
would be difficult to correlate with ChIP data on the 
full set of  variants. However, we demonstrated that the 
VNTR was not in disequilibrium with the GWAS SNP 
(supplementary figure S1). Using the HapMap CEU 
population, we demonstrated a large number of  vari-
ants (4–12 copies) of  the VNTR, although the majority 
of  individuals (55%) were homozygous for the 4-copy 
variant (Table 1). The higher VNTR copy-number vari-
ants are rare within the population, thus giving us little 
power to address the role of  the functionally distinct 
12-copy variant as a simple genetic correlate for risk to 
schizophrenia. Furthermore, it might also suggest that 
the larger copy variants are selected against; further 
work will be required to resolve the role of  the VNTR, 
if  any, in schizophrenia risk.
In summary, the internal Imir137 promoter described 
in this communication can be regulated in an allele-
specific and stimulus-inducible manner in part by the 
transcription factor REST. REST could modulate 
epigenetic parameters in response to environmental 
factors, such as stress, in the medium to long term in 
addition to the immediate changes observed in our cell 
line model. This is consistent with a G × E mechanism 
regulating miR-137, and potentially miR-2682, levels in 
the cell, with alterations in the concentration of  these 
miRNAs resulting in differential repression of  their 
gene targets in response to environmental cues. This 
differential expression directed by REST could be fur-
ther affected by VNTR genotype. The resulting levels 
of  these miRNAs could play a significant role in CNS 
dysfunction, including schizophrenia. This mechanism 
to modulate miR-137 levels is distinct from the mecha-
nism associated with the intronic GWAS SNP, which 
we found not to be in disequilibrium with this internal 
promoter.
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Supplementary material is available at http://schizophre-
niabulletin.oxfordjournals.org.
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